BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24728444)

  • 1. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
    Babu BV; Babu GR
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):538-49. PubMed ID: 24728444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
    Lahariya C; Mishra A
    J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination.
    Alexander ND
    Trans R Soc Trop Med Hyg; 2015 Mar; 109(3):173-4. PubMed ID: 25575555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 7. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
    Modi A; Gamit S; Jesalpura BS; Kurien G; Kosambiya JK
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005476. PubMed ID: 28369129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.
    Ramaiah KD; Vijay Kumar KN; Hosein E; Krishnamoorthy P; Augustin DJ; Snehalatha KS; Nanda B; Das PK
    Ann Trop Med Parasitol; 2006 Jun; 100(4):345-61. PubMed ID: 16762115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India.
    Bashar A; Nandekar SV; Shrivastava P; Singh RN; Srikrishnan P
    J Vector Borne Dis; 2023; 60(3):307-316. PubMed ID: 37843242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
    Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
    J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
    Vanamail P; Ramaiah KD; Subramanian S; Pani SP; Yuvaraj J; Das PK
    Ann Trop Med Parasitol; 2005 Apr; 99(3):237-42. PubMed ID: 15829133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
    Babu BV; Satyanarayana K
    Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
    Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
    J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
    Cantey PT; Rout J; Rao G; Williamson J; Fox LM
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e728. PubMed ID: 20628595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
    Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the factors affecting the MDA programme in Kerala state.
    Showkath Ali MK; Rajendran R; Regu K; Mohanan MK; Dhariwal AC; Lal S
    J Commun Dis; 2007 Mar; 39(1):51-6. PubMed ID: 18338717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.
    Ramaiah KD; Vijay Kumar KN; Chandrakala AV; Augustin DJ; Appavoo NC; Das PK
    Trop Med Int Health; 2001 Dec; 6(12):1062-9. PubMed ID: 11737843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.